Masimo and Philips renewed a multi-year strategic collaboration to integrate patient monitoring technologies and develop new tools, such as artificial intelligence algorithms, that could help improve ...

Philips PHG is leaving no stone unturned to bolster its patient monitoring solutions portfolio on the back of recent collaborations. In this regard, the company partnered with smartQare to integrate ...

As part of the company’s focus on the development of advanced monitoring solutions, Royal Philips (NYSE: PHG; AEX: PHIA) today announced the launch of its IntelliVue patient monitoring platform with ...

Medtech companies Philips and Masimo are expanding their patient monitoring partnership to include the latter's new W1 wearable. The collaboration allows vital sign data from the W1 watch to be sent ...

Systems that monitor vital signs are among the most important tools heath care professionals have at their disposal when looking after a patient. Even small changes to certain vitals can be early ...

Dutch health tech giant Royal Philips has scored FDA 510(k) clearance for its IntelliVue MX750 and MX850 patient monitors. The monitors, which received an FDA emergency use authorization in 2020 and ...

Royal Philips, a global leader in health technology, announced that its Philips Patient Monitors MX750 and MX850 have received 510(k) clearance from the US Food and Drug Administration. Initially ...

A year after they were given an emergency nod to be used during the pandemic, two of Royal Philips’ newest patient monitors now are cleared by the Food and Drug Administration. The agency recently ...

Amsterdam, the Netherlands and Irvine, California, U.S. – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Masimo (NASDAQ: MASI), a global medical technology company, ...

On the earnings call in August, new CEO Katie Szyman, who joined Masimo in February from BD, sought to reassure investors that the company’s decades-long relationship with Philips remained strong.